0000950170-24-007483.txt : 20240125 0000950170-24-007483.hdr.sgml : 20240125 20240125170009 ACCESSION NUMBER: 0000950170-24-007483 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson Michael H. CENTRAL INDEX KEY: 0001573785 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41562 FILM NUMBER: 24563043 MAIL ADDRESS: STREET 1: OMTHERA PHARMACEUTICALS, INC. STREET 2: 707 STATE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NewAmsterdam Pharma Co N.V. CENTRAL INDEX KEY: 0001936258 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC BUSINESS PHONE: 35 206 2971 MAIL ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC FORMER COMPANY: FORMER CONFORMED NAME: NewAmsterdam Pharma Co B.V. DATE OF NAME CHANGE: 20220701 3/A 1 ownership.xml 3/A X0206 3/A 2023-12-29 2023-12-29 0 0001936258 NewAmsterdam Pharma Co N.V. NAMS 0001573785 Davidson Michael H. C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35 NAARDEN P7 1411 DC NETHERLANDS true true false false Chief Executive Officer Warrant (right to buy) 11.50 2022-12-22 2027-11-23 Ordinary Shares 100000 D This amendment is being filed to include warrants to purchase ordinary shares inadvertently omitted from the Form 3 filed by the Reporting Person on December 29, 2023. /s/ Louise Kooij by Power of Attorney for Michael H. Davidson 2024-01-25